Tower Health plans to sell the hospital to Philadelphia-based Temple University Health System, which is partnering with Meadowbrook, Pa.-based Redeemer Health and Philadelphia College of Osteopathic Medicine in the purchase. Temple will manage the 148-bed facility, which had 827 employees in August, according to the report.
The $28 million in cash from the sale would add five days to Tower’s cash reserves, the report said. Another five days of cash reserves would be added from the sale through eliminating losses at the Chestnut Hill location, currently amounting to $11.1 million through August.
Tower Health operates six acute care hospitals and 230 locations overall, serving 2.5 million people.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
